Your browser doesn't support javascript.
loading
Membrane Cholesterol Efflux Drives Tumor-Associated Macrophage Reprogramming and Tumor Progression.
Goossens, Pieter; Rodriguez-Vita, Juan; Etzerodt, Anders; Masse, Marion; Rastoin, Olivia; Gouirand, Victoire; Ulas, Thomas; Papantonopoulou, Olympia; Van Eck, Miranda; Auphan-Anezin, Nathalie; Bebien, Magali; Verthuy, Christophe; Vu Manh, Thien Phong; Turner, Martin; Dalod, Marc; Schultze, Joachim L; Lawrence, Toby.
  • Goossens P; CNRS, Aix Marseille University, INSERM, CIML, Marseille 13009, France; Department of Pathology, Cardiovascular Research Institute Maastricht, Maastricht University, 6229HX Maastricht, the Netherlands.
  • Rodriguez-Vita J; CNRS, Aix Marseille University, INSERM, CIML, Marseille 13009, France; Vascular Signaling and Cancer (A270), German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.
  • Etzerodt A; CNRS, Aix Marseille University, INSERM, CIML, Marseille 13009, France; Department of Biomedicine, Aarhus University, Aarhus 8000, Denmark.
  • Masse M; CNRS, Aix Marseille University, INSERM, CIML, Marseille 13009, France.
  • Rastoin O; CNRS, Aix Marseille University, INSERM, CIML, Marseille 13009, France.
  • Gouirand V; CNRS, Aix Marseille University, INSERM, CIML, Marseille 13009, France.
  • Ulas T; Genomics & Immunoregulation, Life and Medical Sciences Institute (LIMES), University of Bonn, Bonn 53115, Germany; PRECISE Platform for Single Cell Genomics and Epigenomics, German Center for Neurodegenerative Diseases and University of Bonn, Bonn 53127, Germany.
  • Papantonopoulou O; Genomics & Immunoregulation, Life and Medical Sciences Institute (LIMES), University of Bonn, Bonn 53115, Germany.
  • Van Eck M; Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Universiteit Leiden, 2300 Leiden, the Netherlands.
  • Auphan-Anezin N; CNRS, Aix Marseille University, INSERM, CIML, Marseille 13009, France.
  • Bebien M; CNRS, Aix Marseille University, INSERM, CIML, Marseille 13009, France.
  • Verthuy C; CNRS, Aix Marseille University, INSERM, CIML, Marseille 13009, France.
  • Vu Manh TP; CNRS, Aix Marseille University, INSERM, CIML, Marseille 13009, France.
  • Turner M; Laboratory of Lymphocyte Signaling and Development, The Babraham Institute, Cambridge CB22 3AT, UK.
  • Dalod M; CNRS, Aix Marseille University, INSERM, CIML, Marseille 13009, France.
  • Schultze JL; Genomics & Immunoregulation, Life and Medical Sciences Institute (LIMES), University of Bonn, Bonn 53115, Germany; PRECISE Platform for Single Cell Genomics and Epigenomics, German Center for Neurodegenerative Diseases and University of Bonn, Bonn 53127, Germany.
  • Lawrence T; CNRS, Aix Marseille University, INSERM, CIML, Marseille 13009, France; Centre for Inflammation Biology and Cancer Immunology, School of Immunology & Micriboal Sciences, King's College London, London SE1 1UL, UK; Henan Key Laboratory of Immunology and Targeted Therapy, School of Laboratory Medici
Cell Metab ; 29(6): 1376-1389.e4, 2019 06 04.
Article en En | MEDLINE | ID: mdl-30930171
ABSTRACT
Macrophages possess intrinsic tumoricidal activity, yet tumor-associated macrophages (TAMs) rapidly adopt an alternative phenotype within the tumor microenvironment that is marked by tumor-promoting immunosuppressive and trophic functions. The mechanisms that promote such TAM polarization remain poorly understood, but once identified, they may represent important therapeutic targets to block the tumor-promoting functions of TAMs and restore their anti-tumor potential. Here, we have characterized TAMs in a mouse model of metastatic ovarian cancer. We show that ovarian cancer cells promote membrane-cholesterol efflux and depletion of lipid rafts from macrophages. Increased cholesterol efflux promoted IL-4-mediated reprogramming, including inhibition of IFNγ-induced gene expression. Genetic deletion of ABC transporters, which mediate cholesterol efflux, reverts the tumor-promoting functions of TAMs and reduces tumor progression. These studies reveal an unexpected role for membrane-cholesterol efflux in driving TAM-mediated tumor progression while pointing to a potentially novel anti-tumor therapeutic strategy.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Membrana Celular / Colesterol / Reprogramación Celular / Microambiente Tumoral / Macrófagos / Neoplasias Tipo de estudio: Risk_factors_studies Límite: Animals Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Membrana Celular / Colesterol / Reprogramación Celular / Microambiente Tumoral / Macrófagos / Neoplasias Tipo de estudio: Risk_factors_studies Límite: Animals Idioma: En Año: 2019 Tipo del documento: Article